Stem Cells in Cancer and Regenerative MedicineEMBL Heidelberg, Germany Thursday 9 October - Sunday 12 October 2014 Registration deadline: Sunday 17 August 2014
Abstract deadline: Thursday 24 July 2014
- Registration is open.
- Abstract submission extended until 24 July 2014, 23:59 CET.
- Do you have something to tweet? Use this hashtag #EMBLStem
Regenerative medicine is based on the ability of stem cells to repair tissue damage. The regenerative capacity of endogenous stem cells decreases with age, is impaired in degenerative diseases, and deregulated in cancer. Our ability to maintain and restore normal tissue function therefore requires that we understand not only the identity, properties and function of normal stem cells, but also the processes that alter their function during ageing, and in both malignant and degenerative disease. The aim of this conference is to provide a comprehensive overview of these aspects of stem cell biology. The cellular and molecular properties of normal tissue stem cells will be discussed, as will the properties of the niches that maintain them. We will address alterations to stem cell function during ageing and malignant transformation, and how stem cells can be used for regenerative purposes and for disease modeling.
A clear and identifiable strength of this conference has been the broad subject coverage, which promotes an integrated and cross-disciplinary view of stem cell biology and regenerative medicine. This approach is fairly unique among stem cell conferences.
The aim of this meeting is to integrate basic, translational and clinical aspects of stem cell research into a single framework. The goal is to give participants an overview of the model systems and scientific and logistic framework involved in gaining and exploiting basic knowledge of stem cell biology in cancer research and regenerative medicine settings.